20/20 Biolabs (AIDX) vs enVVeno Medical (NVNO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
enVVeno Medical is the larger company by market cap ($5.7 million vs $4.8 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AIDX | NVNO |
|---|---|---|
| Share price | $0.379 | $8.18 |
| Market cap | $4.84M | $5.68M |
| 1-day change | +10.33% | -2.68% |
| EPS (TTM) | $-0.75 | $-24.99 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $50.00 | $30.80 |
| 52-week low | $0.33 | $7.01 |
| Distance from 52-week high | -99.24% | -73.46% |
| Analyst consensus | none | none |
| Avg. price target upside | +1219.26% | +266.97% |
| Average volume | 90.86K | 23.71K |
| Shares outstanding | 12.77M | 694.83K |
| Employees | 4 | 33 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About 20/20 Biolabs
AIDX stock →20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases.
Healthcare · Medical Devices · 4 employees
About enVVeno Medical
NVNO stock →enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency.
Healthcare · Medical Devices · 33 employees
AIDX vs NVNO FAQ
Which is bigger, 20/20 Biolabs or enVVeno Medical?
enVVeno Medical (NVNO) is larger, with a market capitalization of $5.68M compared with $4.84M for 20/20 Biolabs (AIDX).
Are 20/20 Biolabs and enVVeno Medical in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.